Hormone Support
Improves Sexual Function & Overall Health

The mother of all hormones, pregnenolone is a precursor hormone to many other hormones, including DHEA, progesterone, estrogen, testosterone and cortisol. While produced naturally throughout the body, pregnenolone production gradually declines as you age. Stress levels can also affect pregnenolone by causing your body to use up its limited supply to build cortisol (the stress hormone). This “pregnenolone steal” makes it difficult for your body to build up sufficient quantities of other key hormones so you can reach a balanced level that promotes optimal health. Take 1 or more capsules a day or as recommended by your healthcare provider.

  • The Mother of All Hormones

    Pregnenolone (3-alpha-hydroxy-5-beta-pregnen-20-one) is considered the mother of all steroid hormones. It is produced in many places within the body, including the adrenals, brain, liver, skin, testicles and ovaries. Production of pregnenolone usually peaks during youth and begins to gradually decline with age.

    Pregnenolone is a precursor hormone to many downstream hormones, includingDHEA, progesterone, estrogen, testosterone and cortisol. It is vital in promoting homeostasis within the body by allowing the body to decide which hormones it wants to build depending on the body’s physiological needs.

    Today, many Americans experience high levels of stress trying to meet unrealistic expectations and not taking proper care of their physical and mental well-being. There is a limited supply of pregnenolone in the body and during prolonged periods of stress, much of pregnenolone is used to build the stress hormone cortisol. As a result, other hormones cannot be built in sufficient quantities to promote optimal health. This phenomenon is known as the “Pregnenolone Steal.” Supplemental pregnenolone should be used after completing laboratory testing under the supervision of a qualified healthcare practitioner. Pregnenolone can provide the body with more of the “building blocks” it needs to create the necessary hormones to help promote well-being.

    Pregnenolone Research

    An eight-week double-blind, randomized, placebo-controlled trial with participants taking 50 mg of pregnenolone showed significant reductions in visual attention deficits along with a significant improvement in visual and sustained attention.1 Another eight week double-blind, randomized, placebo-controlled trial showed those receiving 30 mg of pregnenolone had an improvement in working memory performance, attention, and saw significant reductions in positive symptom scores.2

    Individuals with mood disorders are often shown to have lower pregnenolone levels compared to controls3. Pregnenolone is reported to have a beneficial effect on neuronal excitability and synaptic plasticity, helping improve cognitive performance and mood regulation.4

    In one study, pregnenolone showed a significant decrease in negative symptoms in patients with schizophrenia or schizoaffective disorder.5 An 8 week randomized, controlled trial demonstrated pregnenolone’s ability to improve functional capacity in schizophrenic patients, significantly increase serum pregnenolone levels, and was shown to be well tolerated.6


    1. Kreinin, A., Bawakny, N., & Ritsner, M. S. Adjunctive pregnenolone ameliorates the cognitive deficits in recent-onset schizophrenia: An 8-week, randomized, double-blind, placebo-controlled trial.

    2. Vallée, M., Mayo, W., & Le Moal, M. (2001). Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging.Brain Research Reviews,37(1), 301-312.

    3. Ritsner, M., Maayan, R., Gibel, A., & Weizman, A. (2007). Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects.European Neuropsychopharmacology,17(5), 358-365.

    4. Ritsner, M. S. Pregnenolone, dehydroepiandrosterone, and schizophrenia: alterations and clinical trials. CNS Neurosci Ther. 2010; 16(1):32-44).

    5. Marx, C. E., Bradford, D. W., Hamer, R. M., Naylor, J. C., Allen, T. B., Lieberman, J. A., ... & Kilts, J. D. (2011). Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence.Neuroscience,191, 78-90.

    6. Marx, C. E., Lee, J., Subramaniam, M., Rapisarda, A., Bautista, D. C., Chan, E., ... & Chong, S. A. (2014). Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia.Psychopharmacology,231(17), 3647-3662.


    * These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.


Subscribe for More!

Reward Points

Welcome to the Loyalty Points Demo Store :-)

Sign up and receive 5000 pts to test out in our Store.

Earning and redeeming Good Health Points

Earns you
Redeems to

Ways you can earn

  • Product Purchase
  • Refer a friend
  • Share on social media

Learn more about our program